NDC11 73070040011
This exact 11-digit normalized identifier can correspond to more than one FDA hyphenation. FDA.report preserves the exact identifier and exposes every structurally valid candidate without guessing.
Possible FDA NDC forms#
| Package NDC | Product root |
|---|---|
| 73070-0400-11 | 73070-0400 |
| 73070-400-11 | 73070-400 |
openFDA label cross-check#
OpenFDA label data provides additional search and identifier links. DailyMed’s Structured Product Label is the canonical label on FDA.report. Matching records are deduplicated before they are shown below.
| Brand | Generic | Manufacturer | SPL set ID | Effective date | Available safety fields | Join |
|---|---|---|---|---|---|---|
| Insulin Degludec | INSULIN DEGLUDEC | Novo Nordisk Pharma, Inc. | c1be283d-4b1d-4996-b2a7-4488dbff3037 | 2022-07-01 | Warnings, Adverse reactions | 73070-400-11 73070-400 73070040011 |
Reported adverse events (FAERS/openFDA)#
Adverse event summaries are temporarily unavailable. Other product information remains available.